Company logo

SRDX - Surmodics, Inc.

NASDAQ -> Healthcare -> Medical Devices
Eden Prairie, United States
Type: Equity

SRDX price evolution
SRDX
(in millions $) 31 Jan 2023 30 Sep 2022 30 Jun 2022 31 Mar 2022
Current assets
Cash $19 $20.07 $24.71
Short term investments $2.01 $2.01
Net receivables $10.45 $9.38 $11.04
Inventory $11.82 $10.93 $9.47
Total current assets $57.59 $60.03 $64.68
Long term investments
Property, plant & equipment $27.15 $28.29 $29.08
Goodwill & intangible assets $68.86 $73.34 $77.76
Total noncurrent assets $100.77 $115.62 $119.51
Total investments $2.01 $2.01
Total assets $158.36 $175.65 $184.19
Current liabilities
Accounts payable $3.14 $1.93 $2.11
Deferred revenue $9.25 $11.41 $12.44
Short long term debt $10 $10 $10
Total current liabilities $32.08 $29.39 $28.37
Long term debt
Total noncurrent liabilities $17.89 $21.15 $22.55
Total debt $10 $10 $10
Total liabilities $49.97 $50.54 $50.92
Shareholders' equity
Retained earnings $88.79 $103.52 $109.17
Other shareholder equity -$9.87 -$5.72 -$1.43
Total shareholder equity $108.39 $125.11 $133.26
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $19 $31.15 $30.79 $30.36
Short term investments $7.72 $30.31 $24.93
Net receivables $10.45 $9.17 $7.67 $8.99
Inventory $11.82 $6.76 $5.97 $4.5
Total current assets $57.59 $70.25 $86.61 $81.42
Long term investments $2
Property, plant & equipment $27.15 $30.09 $30.1 $29.75
Goodwill & intangible assets $68.86 $82.66 $40.47 $40.4
Total noncurrent assets $100.77 $124.34 $82.16 $78.44
Total investments $9.72 $30.31 $24.93
Total assets $158.36 $194.59 $168.76 $159.87
Current liabilities
Accounts payable $3.14 $1.78 $1.51 $2.08
Deferred revenue $9.25 $14.95 $16 $17.18
Short long term debt $10 $10
Total current liabilities $32.08 $29.82 $18.89 $20.21
Long term debt
Total noncurrent liabilities $17.89 $24.69 $18.82 $17.14
Total debt $10 $10
Total liabilities $49.97 $54.51 $37.71 $37.35
Shareholders' equity
Retained earnings $88.79 $116.06 $111.83 $110.7
Other shareholder equity -$9.87 $1.73 $3.17 $0.4
Total shareholder equity $108.39 $140.09 $131.06 $122.52
(in millions $) 31 Jan 2023 30 Sep 2022 30 Jun 2022 31 Mar 2022
Revenue
Total revenue $25.99 $24.85 $26.11
Cost of revenue $5.6 $5.14 $5.11
Gross Profit $20.39 $19.71 $21
Operating activities
Research & development $12.26 $12.97 $13.71
Selling, general & administrative $13.78 $12.85 $11.11
Total operating expenses $27.18 $26.89 $25.9
Operating income -$6.79 -$7.18 -$4.9
Income from continuing operations
EBIT -$6.6 -$7.04 -$4.87
Income tax expense $7.94 -$1.53 -$0.92
Interest expense $0.19 $0.14 $0.13
Net income
Net income -$14.73 -$5.65 -$4.08
Income (for common shares) -$14.73 -$5.65 -$4.08
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Revenue
Total revenue $99.95 $105.14 $94.86 $100.08
Cost of revenue $20.34 $17.18 $15.32 $13.64
Gross Profit $79.61 $87.96 $79.55 $86.44
Operating activities
Research & development $50.61 $46.73 $50.19 $52.88
Selling, general & administrative $46.94 $30.68 $28.39 $23.95
Total operating expenses $102.1 $81.26 $80.8 $79.97
Operating income -$22.49 $6.7 -$1.25 $6.47
Income from continuing operations
EBIT -$21.89 $6.66 -$1.32 $7.71
Income tax expense $4.78 $2.11 -$2.58 -$0.03
Interest expense $0.6 $0.31 $0.13 $0.15
Net income
Net income -$27.27 $4.24 $1.12 $7.59
Income (for common shares) -$27.27 $4.24 $1.12 $7.59
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Net income -$14.73 -$5.65 -$4.08 -$2.81
Operating activities
Depreciation $2.4 $2.37 $2.44 $2.47
Business acquisitions & disposals
Stock-based compensation $1.86 $1.8 $1.72 $1.68
Total cash flows from operations -$2.5 -$3.5 -$4.2 -$7.03
Investing activities
Capital expenditures -$0.57 -$0.86 -$1.16 -$0.78
Investments $2 $3.6 $4
Total cash flows from investing $1.43 -$0.86 $2.44 $3.22
Financing activities
Dividends paid
Sale and purchase of stock $0.48 $0.02 $0.51 $0.23
Net borrowings
Total cash flows from financing $0.3 -$0.01 -$0.04 -$0.62
Effect of exchange rate -$0.3 -$0.27 -$0.15 -$0.07
Change in cash and equivalents -$1.08 -$4.64 -$1.94 -$4.5
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$27.27 $4.24 $1.12 $7.59
Operating activities
Depreciation $9.67 $8.32 $7.51 $7.31
Business acquisitions & disposals -$40.55 -$0.75
Stock-based compensation $7.06 $5.86 $5.45 $5.08
Total cash flows from operations -$17.22 $15.39 $14.01 $8.04
Investing activities
Capital expenditures -$3.37 -$5.28 -$3.67 -$5.99
Investments $9.6 $20.59 -$5.39 $16.49
Total cash flows from investing $6.23 -$25.24 -$9.07 $9.75
Financing activities
Dividends paid
Sale and purchase of stock $1.25 $3.13 $1.61 $0.72
Net borrowings $10 -$0.14
Total cash flows from financing -$0.38 $10.23 -$4.65 -$11.03
Effect of exchange rate -$0.79 -$0.01 $0.13 -$0.07
Change in cash and equivalents -$12.15 $0.37 $0.42 $6.69
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 0.46
Net debt/EBITDA N/A
Current ratio N/A
Quick ratio N/A